Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000921895-21-001531
Filing Date
2021-06-02
Accepted
2021-06-02 16:35:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 defa14a12566010_05282021.htm DEFA14A 44835
  Complete submission text file 0000921895-21-001531.txt   46005
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36866 | Film No.: 21989616
SIC: 2834 Pharmaceutical Preparations